Abramson, Alex http://orcid.org/0000-0003-4876-9751
Frederiksen, Morten Revsgaard http://orcid.org/0000-0003-0000-4426
Vegge, Andreas
Jensen, Brian
Poulsen, Mette
Mouridsen, Brian
Jespersen, Mikkel Oliver
Kirk, Rikke Kaae
Windum, Jesper
Hubálek, František http://orcid.org/0000-0003-3983-7900
Water, Jorrit J.
Fels, Johannes http://orcid.org/0000-0002-6616-6746
Gunnarsson, Stefán B.
Bohr, Adam
Straarup, Ellen Marie
Ley, Mikkel Wennemoes Hvitfeld
Lu, Xiaoya
Wainer, Jacob
Collins, Joy
Tamang, Siddartha
Ishida, Keiko
Hayward, Alison
Herskind, Peter
Buckley, Stephen T. http://orcid.org/0000-0001-9804-7242
Roxhed, Niclas http://orcid.org/0000-0002-7147-6730
Langer, Robert http://orcid.org/0000-0003-4255-0492
Rahbek, Ulrik http://orcid.org/0000-0002-1255-0232
Traverso, Giovanni http://orcid.org/0000-0001-7851-4077
Funding for this research was provided by:
National Science Foundation
Novo Nordisk
Viking Olof Björk scholarship trust
U.S. Department of Health & Human Services | National Institutes of Health (EB-000244, EB-000244)
Massachusetts Institute of Technology
Viking Olof Björk scholarship trust
Article History
Received: 8 April 2020
Accepted: 16 July 2021
First Online: 30 August 2021
Competing interests
: M.R.F., M.P., A.V., B.M., F.H., J.J.W., J.F., R.K.K., S.B.G., E.M.S., S.T.B., P.H., M.O.J., J. Windum, A.B., E.S. and U.R. are employees of Novo Nordisk. M.W.H.L. and B.J. are hired as consultants for Novo Nordisk. A.A., M.R.F., A.V., M.P., J.J.W., M.W.H.L., B.J., J. Windum, J. Wainer, X.L., N.R., U.R., G.T. and R.L. are co-inventors on patent applications describing oral biologic drug delivery. A.A., R.L. and G.T. report receiving consulting fees from Novo Nordisk. A.A. reports receiving consulting fees from Eli Lilly. Complete details of all relationships for profit and not for profit for G.T. can found at the following link: ExternalRef removed. For a list of entities with which R.L. is involved, compensated or uncompensated, see ExternalRef removed.